Here, we revealed that RAC3 activated the AKT/NF-κB pathway, and RAC3-mediated AKT/NF-κB pathway activation was responsible for CAFs' effect on NSCLC cell migration. This evidence concerns the gene RAC3 and non-small cell lung carcinoma.